Shan Lu, MD, PhD

Director, Laboratory of Nucleic Acid Vaccines; Professor, Department of Medicine; University of Massachusetts Medical School, Worcester, Massachusetts, USA

Dr. Lu is a physician scientist with research interest in novel vaccine development. Currently he is a tenured professor and Director of Laboratory of Nucleic Acid Vaccines in the Department of Medicine at the University of Massachusetts Medical School, USA.

Dr. Lu received his medical education at Nanjing Medical College, China, and graduate studies at the University of Massachusetts Medical School, USA. He was a Howard Hughes Physician Research Fellow and completed his residency training in Internal Medicine at the University of Massachusetts Medical Center and became a board certified attending physician in Internal Medicine. He is a Fellow of American College of Physicians (FACP).

Dr. Lu's research interests are in the development of novel vaccines against emerging infectious diseases and biodefense targets. He was one of the pioneers in developing DNA vaccine technology and has applied this technology to developing a polyvalent DNA prime-protein boost HIV vaccine which showed high immunogenicity in human studies including broadly cross-reactive antibodies. He has also used DNA immunization to generate highly functional monoclonal antibodies from mice, rabbit and healthy human volunteers against a wide range of infectious disease and non-infectious disease targets.

Dr. Lu has been a member of the Executive Board of International Society for Vaccines (ISV) since 2008 and served as ISV President from 2011-2013. He has been the chief organizer for ISV’s annual global congress in the last 10 years. He is a Fellow of ISV (FISV). He is a member of the Editorial Boards for Journal of Virology, Vaccine, Nature’s NPj-Vaccines and several other journals. He is the founding Deputy Editor-in-Chief for Emerging Microbes and Infections, published by Nature Publishing Group (NPG). Dr. Lu has co-authored over 200 research papers and chapters. He is also an Honorary Professor of Fudan University and the Chair of International Scientific Advisory Committee for China’s National Engineering Laboratory of Therapeutic Vaccines.